Pan-Immune-Inflammatory Value (PIV) and HALP Score as Independent Prognostic Indicators in Acute Coronary Syndrome Patients
Journal of Clinical Medicine · 22.02.2026 · 15 (4) · 1660
DOI: 10.3390/jcm15041660 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.02.2026. Verfasst von Azmi Eyiol und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beyhekim Training and Research Hospital, 42100 Konya, Turkey. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Acute coronary syndrome (ACS), encompassing unstable angina, NSTEMI, and STEMI, is a major cause of morbidity and mortality worldwide. Novel inflammatory and nutritional biomarkers may provide incremental value for risk stratification beyond conventional predictors. This work sought to determine whether the Pan-Immune-Inflammatory Value (PIV) and the Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) score could serve as independent prognostic indicators in individuals presenting with acute coronary syndrome.
Methods
A retrospective multicenter study included ACS patients hospitalized between January 2020 and May 2024. Demographics, clinical data, and laboratory results were collected. PIV was calculated as follows: neutrophils × platelets × monocytes/lymphocytes. HALP score was calculated as follows: hemoglobin × albumin × lymphocytes/platelets. Correlations with clinical parameters and mortality prediction were analyzed.
Results
A total of 1134 patients (mean age 62 ± 12 years) were included. PIV showed positive correlations with WBC (Rho = 0.574), troponin (Rho = 0.381), and CRP (Rho = 0.295), and negative correlations with HDL (Rho = –0.101) and ejection fraction (Rho = –0.316) (all p < 0.01). PIV independently predicted mortality with a cut-off ≥1074.2 (AUC = 0.619, sensitivity 45%, specificity 79.9%). HALP score negatively correlated with age, troponin, CRP, and ICU stay, and predicted mortality with a cut-off ≤3.58 (AUC = 0.722, sensitivity 53.8%, specificity 82%). Comparative ROC analysis showed that HALP demonstrated superior discriminative ability for mortality prediction compared with PIV.
Conclusions
PIV and HALP score are independent prognostic markers in ACS, reflecting inflammatory burden and nutritional status. Their integration into clinical workflows may enhance risk stratification and support individualized management strategies. Given their simplicity and universal availability, PIV and HALP may serve as practical adjunctive tools to established risk scores, enabling early identification of high-risk ACS patients at the time of admission.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Beyhekim Training and Research Hospital, 42100 Konya, Turkey.
- Department of Anesthesiology and Reanimation, Beyhekim Training and Research Hospital, 42100 Konya, Turkey.
- Department of Cardiology, Faculty of Medicine, Karamanoğlu Mehmetbey University, 70100 Karaman, Turkey.
- Department of Cardiology, Kemer State Hospital, 07100 Antalya, Turkey.
Zitieren
APA
Eyiol, A., Eyiol, H., Yilmaz, A., & Sari, H. (2026). Pan-Immune-Inflammatory Value (PIV) and HALP Score as Independent Prognostic Indicators in Acute Coronary Syndrome Patients. Journal of Clinical Medicine, 15(4), 1660. https://doi.org/10.3390/jcm15041660
Vancouver
Eyiol A, Eyiol H, Yilmaz A, Sari H. Pan-Immune-Inflammatory Value (PIV) and HALP Score as Independent Prognostic Indicators in Acute Coronary Syndrome Patients. Journal of Clinical Medicine. 2026;15(4):1660. doi:10.3390/jcm15041660
BibTeX
@article{Eyiol2026,
author = {Eyiol, Azmi and Eyiol, Hatice and Yilmaz, Ahmet and Sari, Hasan},
title = {Pan-Immune-Inflammatory Value (PIV) and HALP Score as Independent Prognostic Indicators in Acute Coronary Syndrome Patients},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {4},
pages = {1660},
doi = {10.3390/jcm15041660}
}
EUVIMED